Irelli A, Patruno L, Chiatamone Ranieri S, Di Giacomo D, Malatesta S, Alesse E
Biomedicines. 2024; 12(4).
PMID: 38672070
PMC: 11048717.
DOI: 10.3390/biomedicines12040714.
Wong S, Apostolova C, Eisenberg E, Foulkes W
Curr Oncol. 2024; 31(1):350-365.
PMID: 38248108
PMC: 10814079.
DOI: 10.3390/curroncol31010023.
Farncombe K, Wong D, Norman M, Oldfield L, Sobotka J, Basik M
Am J Hum Genet. 2023; 110(10):1616-1627.
PMID: 37802042
PMC: 10577078.
DOI: 10.1016/j.ajhg.2023.08.014.
Abdel-Razeq H
Front Oncol. 2023; 13:1265197.
PMID: 37781190
PMC: 10539549.
DOI: 10.3389/fonc.2023.1265197.
Schiaffino S, Cozzi A, Pompei B, Scarano A, Catanese C, Catic A
J Clin Med. 2023; 12(13).
PMID: 37445444
PMC: 10342840.
DOI: 10.3390/jcm12134410.
Diverse genetic spectrum among patients who met the criteria of hereditary breast, ovarian and pancreatic cancer syndrome.
Lin P, Tien Y, Cheng W, Chiang Y, Wu C, Yang K
J Gynecol Oncol. 2023; 34(5):e66.
PMID: 37170728
PMC: 10482589.
DOI: 10.3802/jgo.2023.34.e66.
What Is Known about Breast Cancer in Young Women?.
Zhu J, Charkhchi P, Adekunte S, Akbari M
Cancers (Basel). 2023; 15(6).
PMID: 36980802
PMC: 10047861.
DOI: 10.3390/cancers15061917.
Molecular Histopathology for Establishing Diagnostic Method and Clinical Therapy for Ovarian Carcinoma.
Hayashi T, Konishi I
J Clin Med Res. 2023; 15(2):68-75.
PMID: 36895622
PMC: 9990723.
DOI: 10.14740/jocmr4853.
Hereditary Women's Cancer: Management and Risk-Reducing Surgery.
Conte C, Pelligra S, Sarpietro G, Montana G, Della Corte L, Bifulco G
Medicina (Kaunas). 2023; 59(2).
PMID: 36837501
PMC: 9967188.
DOI: 10.3390/medicina59020300.
The Psychosocial Impact of the Decision to Undergo Risk-Reducing Salpingo-Oophorectomy Surgery in Mutation Carriers and the Role of Physician-Patient Communication.
Alves-Nogueira A, Melo D, Carona C, Figueiredo-Dias M
Curr Oncol. 2023; 30(2):2429-2440.
PMID: 36826146
PMC: 9955232.
DOI: 10.3390/curroncol30020185.
Distinct breast cancer phenotypes in BRCA 1/2 carriers based on ER status.
Rosenberg S, Devir M, Kaduri L, Grinshpun A, Miner V, Hamburger T
Breast Cancer Res Treat. 2023; 198(2):197-205.
PMID: 36729248
DOI: 10.1007/s10549-022-06851-6.
Metastatic colorectal cancer as the primary phenotype in a hereditary breast and ovarian cancer patient with Germline BRCA1 mutation: a case report.
Liu Y, Zhu J, Wei X, Yang D, Li S, Qian X
J Ovarian Res. 2022; 15(1):127.
PMID: 36463302
PMC: 9719216.
DOI: 10.1186/s13048-022-01069-y.
Molecular Management of High-Grade Serous Ovarian Carcinoma.
Punzon-Jimenez P, Lago V, Domingo S, Simon C, Mas A
Int J Mol Sci. 2022; 23(22).
PMID: 36430255
PMC: 9692799.
DOI: 10.3390/ijms232213777.
Factors associated with the decision to undergo risk-reducing salpingo-oophorectomy among women at high risk for hereditary breast and ovarian cancer: a systematic review.
Park S, Kim Y, Kim S
Korean J Women Health Nurs. 2022; 26(4):285-299.
PMID: 36312308
PMC: 9328615.
DOI: 10.4069/kjwhn.2020.11.19.
Hereditary Ovarian Cancer: Towards a Cost-Effective Prevention Strategy.
Ghose A, Bolina A, Mahajan I, Raza S, Clarke M, Pal A
Int J Environ Res Public Health. 2022; 19(19).
PMID: 36231355
PMC: 9565024.
DOI: 10.3390/ijerph191912057.
Surgical Management of Inherited Breast Cancer: Role of Breast-Conserving Surgery.
Magnoni F, Sacchini V, Veronesi P, Bianchi B, Bottazzoli E, Tagliaferri V
Cancers (Basel). 2022; 14(13).
PMID: 35805017
PMC: 9265273.
DOI: 10.3390/cancers14133245.
Polygenic risk scores indicate extreme ages at onset of breast cancer in female BRCA1/2 pathogenic variant carriers.
Borde J, Laitman Y, Blumcke B, Niederacher D, Weber-Lassalle K, Sutter C
BMC Cancer. 2022; 22(1):706.
PMID: 35761208
PMC: 9238030.
DOI: 10.1186/s12885-022-09780-1.
Recommendation and Acceptance of Counselling for Familial Cancer Risk in Newly Diagnosed Breast Cancer Cases.
Kast K, Hafner J, Schrock E, Jahn A, Werner C, Meisel C
Breast Care (Basel). 2022; 17(2):153-158.
PMID: 35702497
PMC: 9149417.
DOI: 10.1159/000517021.
Personalised Risk Prediction in Hereditary Breast and Ovarian Cancer: A Protocol for a Multi-Centre Randomised Controlled Trial.
Archer S, Fennell N, Colvin E, Laquindanum R, Mills M, Dennis R
Cancers (Basel). 2022; 14(11).
PMID: 35681696
PMC: 9179465.
DOI: 10.3390/cancers14112716.
Changes in Sex Steroids and Relation With Menopausal Complaints in Women Undergoing Risk-reducing Salpingo-oophorectomy.
van Winden L, Vermeulen R, van den Noort V, Gaarenstroom K, Kenter G, Brood-van Zanten M
J Endocr Soc. 2022; 6(6):bvac069.
PMID: 35592509
PMC: 9113512.
DOI: 10.1210/jendso/bvac069.
